Search Results 161-170 of 20589 for Ulcerative+colitis

  1. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... Ulcerative Colitis (FIGARO UC 302). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  2. Infliximab (intravenous route) - Mayo Clinic

    Description. Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and ...

  3. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...

  4. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  5. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001).

  6. Mucus in stool: A concern? - Mayo Clinic

    Bloody mucus in stool or mucus along with belly pain may signal a more serious condition, such as Crohn's disease, ulcerative colitis and even cancer. There ...

  7. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.

  8. A Study to Assess Effectiveness and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis. Participation ...

  9. Comparing modalities for detecting dysplasia in patients with IBD - Mayo Clinic

    People with inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are at increased risk of developing colorectal cancer compared ...

  10. Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical ... IBD medicine as well as the IBD drugs azathioprine and mercaptopurine.